Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Revue du Rhumatisme (Edition Francaise) is Scopus-indexed (Q4, CiteScore 0.1). It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 1169-8330Verify ISSN ↗1768-3130Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$2,720 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Rheumatology | 77 / 77 | 0th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present (also 1993–1994, 1961), best quartile Q4, CiteScore 0.1.
Revue du Rhumatisme (Edition Francaise) is Q4 in Rheumatology (rank 77 of 77), by CiteScore 2025.
Revue du Rhumatisme (Edition Francaise) is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 0th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.108, quartile Q4, with an H-index of 16.
The publisher lists an article processing charge of about US$2,720 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Revue du Rhumatisme (Edition Francaise) is published by Elsevier Masson s.r.l. Its print ISSN is 1169-8330 and its online ISSN is 1768-3130.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Revue du Rhumatisme (Edition Francaise) has an h-index of 20 and a 2-year mean of 0.05 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #73 of 74 Scopus journals in Rheumatology.
Revue du Rhumatisme (Edition Francaise) published 659 papers in 2025; its busiest recent year was 2023 with 729. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2026), authors are most often from France (90.4%), United States (2.8%) and Burkina Faso (1.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.